Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 31 - 40 of 120 results for "Biotech"

Behavioural tools to limit losses, fear

ALLY SELBY  |  THURSDAY, 14 MAY 2020
... are gripped by fear or risk aversion. If clients are being overconfident, for example by wanting to scoop up the hottest biotech stock of the moment, she suggests discussing how these new ideas can fit into their long-term strategy. "That way you can ...

Healthcare outperforms as financials plummet

ALLY SELBY  |  FRIDAY, 17 APR 2020
The COVID-19 pandemic has seen Australia's healthcare sector soar as our financials, energy and real estate sectors plummet. However, S&P Dow Jones Indices senior director of global equity indices Michael Orzano said it's a trend that has been ...

US senators in alleged COVID-19 insider trading

JAMIE WILLIAMSON  |  MONDAY, 23 MAR 2020
... Feinstein also sits on the intelligence committee and is also reported to have sold off stocks, unloading up to $10 million in biotech stocks on the back of the briefing between her and her husband. Further, the New York Post alleges Senator Jim Inhofe ...

New fund invests $45m in SA

ELIZA BAVIN  |  FRIDAY, 17 JAN 2020
A new fund has invested $45 million into the South Australian health and biotech industries. The Chinese fund has invested the money to accelerate the development and commercialization of health and medical research outcomes from South Australia. The ...

Salaries of the rich and famous

ALLY SELBY  |  FRIDAY, 20 DEC 2019
... highest paid chief executives at $18 million, followed by property developer Goodman's Gregory Goodman ($12.8 million) and biotech giant CSL's Paul Perreault ($11.7 million). Only two other chief executives netted an annual salary more than $10 million ...

Manager vacancy at $50m fund

KANIKA SOOD  |  WEDNESDAY, 28 AUG 2019
... from the initial investment date. The fund will look at eligible companies across all industries except life science and biotech companies (unless they have demonstrated phase one clinical trial results), or if their main activity is property development ...

ETF issuer hires Olympian

KANIKA SOOD  |  FRIDAY, 23 NOV 2018
... more than $1 billion in exchange-traded money. It has 14 funds, including one launched earlier this month that focuses on biotech stocks. ETF Securities Australia chief executive Kris Walesby said the business has more than doubled its headcount since ...

ETPs attracting money despite volatility

KANIKA SOOD  |  TUESDAY, 13 NOV 2018
... over international equity ETFs, which have become more expensive as the Australian dollar has weakened," Neiron said. New biotech ETF Last week, ETF Securities launched a new ETF that will invest in 120 international healthcare biotech stocks for a fee ...

Praemium FUA surpasses $8bn

KARREN VERGARA  |  FRIDAY, 13 JUL 2018
... at the time of publication, the highest since January 2007. We recently profiled Ohanessian's career from running a biotech company to spearheading Praemium's growth trajectory. Read about it here.

Fintech success insignificant so far: Fahy

JAMIE WILLIAMSON  |  MONDAY, 5 JUN 2017
... operating in the 'toy domain', with the industry yet to be disrupted in any meaningful way. Drawing a comparison to the biotech sector, Association of Superannuation Funds of Australia chief executive Martin Fahy said fintech success stories don't stack ...